← FDA DRUG APPROVALS

FDA ANDA · ANDA089018

TRIPROLIDINE AND PSEUDOEPHEDRINE HYDROCHLORIDES W/ CODEINE

Sponsor: CENCI

APPLICATION
ANDA089018
TYPE
ANDA
ORIGINAL APPROVAL
1986-07-23
LATEST ACTION
1992-09-28
ROUTE
ORAL
DOSAGE FORM
SYRUP
MARKETING STATUS
Discontinued

Products

TRIPROLIDINE AND PSEUDOEPHEDRINE HYDROCHLORIDES W/ CODEINEDiscontinued
CODEINE PHOSPHATE 10MG/5ML, PSEUDOEPHEDRINE HYDROCHLORIDE 30MG/5ML, TRIPROLIDINE HYDROCHLORIDE 1.25MG/5ML · SYRUP · ORAL

Approval history

1992-09-28Labeling · Supplement 3AP
1986-07-23OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →